Paul-Ehrlich-Institut

Go to:

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

News

Date Title
07.07.2025 New EMA Guideline for Allergens: Important Step for Access to Care and Innovation in Allergy Diagnostics and Therapy
26.06.2025 ZEPAI Contributes Expertise in the Field of Pandemic Readiness and Vaccine Supply to the European Vaccine Hub
20.06.2025 Bulletin on Drug Safety - Current Issue 2/2025 Published
13.06.2025 World Blood Donor Day – Paul-Ehrlich-Institut Continuously Strengthens Blood Product Safety
04.06.2025 The Paul-Ehrlich-Institut Issued a Marketing Authorisation in Exceptional Circumstances in May 2025 for the Bultavo 3 Vaccine
30.05.2025 #VaccineFacts Continue Their Impact: The Paul-Ehrlich-Institut Provides Vaccine Information – Even Beyond the Digital Awareness Campaign
21.05.2025 Frequency and Causes of ABO-Incompatible Transfusion of Red Blood Cells
25.04.2025 European Immunisation Week 2025: Strengthening Vaccination Protection Against Measles and HPV
23.04.2025 Paul-Ehrlich-Institut in Exchange with the German Pharmaceutical Industry Association (BPI) on the Regulation of Biomedicines
17.04.2025 World Haemophilia Day – The Paul-Ehrlich-Institut Is Committed to Providing Safe and Innovative Treatment Options for Haemophilia
11.04.2025 Construction Permit Granted for Media Channel
08.04.2025 Veterinary Medicine Safety Day 2025 – Report Adverse Events to Improve the Safety of Veterinary Medicinal Products
03.04.2025 Girls' and Boys' Day 2025 – 21 Young People Learn About Professional Fields at the Paul-Ehrlich-Institut
31.03.2025 Pharmacovigilance Report on the Use of COVID-19 Vaccines – Status as of 31 December 2024
31.03.2025 Use Caution Regarding Commercial Treatment Offers of Unauthorised / Unapproved Advanced Therapy Medicinal Products
31.03.2025 Bulletin on Drug Safety - Current Issue 1/2025 Published
18.03.2025 Flu Vaccine Orders Should be Submitted by Doctors and Pharmacists Immediately
13.03.2025 Permission for Use of Three Bluetongue Vaccines Extended
07.03.2025 Paul-Ehrlich-Institut Publishes Report on Notifications in Accordance with Section 21 of the Transfusion Act for 2023
06.03.2025 Award Procedure for Planning Disciplines Successfully Completed: Building Design and Partners Decided
07.05.2025 Paul-Ehrlich-Institut Permits Import of Two Further Batches Beyfortus with French Labelling
28.02.2025 Rare Disease Day: Innovative Medicinal Products for Better Therapies
10.02.2025 Invitation to Apply for the Langen Science Award 2025
30.01.2025 Paul-Ehrlich-Institut Supports World Neglected Tropical Diseases Day
13.03.2025 The Committee for Veterinary Medicinal Products Recommends Authorisation of First Bluetongue Virus Serotype 3 Vaccines